表紙：クローニング・突然変異誘発の世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、製品別、技術別、最終用途別、地域別、セグメント予測

市場調査レポート

商品コード

1191434

クローニング・突然変異誘発の世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、製品別、技術別、最終用途別、地域別、セグメント予測

Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030

出版日: 2022年12月01日 | 発行: Polaris Market Research

| ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 665,465円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 822,045円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 978,625円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のクローニング・突然変異誘発の市場規模は、2030年までに92億9,000万米ドルに達すると予想されています。

当レポートでは、世界のクローニング・突然変異誘発市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

業界のスナップショット
市場力学
- 促進要因と機会
- 抑制要因と課題
ポーターのファイブフォース分析
- 供給企業の交渉力（中）
- 新規参入者の脅威（低）
- 買い手の交渉力（中）
- 代替の脅威（中）
- 既存企業間の競争（高）
PESTLE分析
業界の動向
バリューチェーン分析
COVID-19の影響分析

第5章世界のクローニング・突然変異誘発市場：製品別

主な調査結果
イントロダクション
- 製品別の世界市場（2018年～2030年）
クローニングキット
- クローニングキット別、地域別（2018年～2030年）
突然変異誘発キット
- 突然変異誘発キット別、地域別（2018年～2030年）

第6章世界のクローニング・突然変異誘発市場：技術別

主な調査結果
イントロダクション
- 技術別の世界市場（2018年～2030年）
TOPO PCRクローニング
- TOPO PCRクローニング別、地域別（2018年～2030年）
部位特異的突然変異誘発
- 部位特異的突然変異誘発別、地域別（2018年～2030年）

第7章世界のクローニング・突然変異誘発市場：最終用途別

主な調査結果
イントロダクション
- 最終用途別の世界市場（2018年～2030年）
バイオ医薬品・製薬
- バイオ医薬品・製薬別、地域別（2018年～2030年）
CRO・CMO
- CRO・CMO別、地域別（2018年～2030年）

第8章世界のクローニング・突然変異誘発市場：地域別

主な調査結果
イントロダクション
- クローニング・突然変異誘発市場の評価：地域別（2018年～2030年）
北米
- 製品別（2018年～2030年）
- 最終用途別（2018年～2030年）
- 技術別（2018年～2030年）
- 米国
- カナダ
欧州
- 製品別（2018年～2030年）
- 最終用途別（2018年～2030年）
- 技術別（2018年～2030年）
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
アジア太平洋地域
- 製品別（2018年～2030年）
- 最終用途別（2018年～2030年）
- 技術別（2018年～2030年）
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
中東・アフリカ
- 製品別（2018年～2030年）
- 最終用途別（2018年～2030年）
- 技術別（2018年～2030年）
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
ラテンアメリカ
- 製品別（2018年～2030年）
- 最終用途別（2018年～2030年）
- 技術別（2018年～2030年）
- メキシコ
- ブラジル
- アルゼンチン

第9章競合情勢

拡張と買収の分析
- 拡張
- 買収
パートナーシップ/コラボレーション/協定/展示会

第10章企業プロファイル

Agilent Technologies, Inc
Thermo Fisher Scientific, Inc
New England Biolabs
Takara Bio Inc
Merck KGaA
Promega Corporation
Bio-Rad Laboratories, Inc
Danaher
Jena Bioscience GmbH
Assay Genie
TransGen Biotech Co., Ltd

図表

List of Tables

Table 1 Global Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 2 Global Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 3 Global Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 4 Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Table 5 North America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 6 North America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 7 North America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 8 U.S.: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 9 U.S.: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 10 U.S.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 11 Canada: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 12 Canada: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 13 Canada: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 14 Europe: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 15 Europe: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 16 Europe: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 17 UK: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 18 UK: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 19 UK: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 20 France: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 21 France: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 22 France: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 23 Germany: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 24 Germany: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 25 Germany: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 26 Italy: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 27 Italy: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 28 Italy: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 29 Spain: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 30 Spain: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 31 Spain: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 32 Netherlands: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 33 Netherlands: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 34 Netherlands: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 35 Russia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 36 Russia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 37 Russia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 38 Asia Pacific: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 39 Asia Pacific: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 40 Asia Pacific: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 41 China: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 42 China: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 43 China: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 44 India: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 45 India: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 46 India: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 47 Malaysia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 48 Malaysia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 49 Malaysia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 50 Japan: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 51 Japan: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 52 Japan: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 53 Indonesia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 54 Indonesia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 55 Indonesia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 56 South Korea: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 57 South Korea: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 58 South Korea: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 59 Middle East & Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 60 Middle East & Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 61 Middle East & Africa: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 62 Saudi Arabia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 63 Saudi Arabia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 64 Saudi Arabia: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 65 UAE: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 66 UAE: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 67 UAE: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 68 Israel: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 69 Israel: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 70 Israel: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 71 South Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 72 South Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 73 South Africa: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 74 Latin America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 75 Latin America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 76 Latin America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 77 Mexico: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 78 Mexico: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 79 Mexico: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 80 Brazil: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 81 Brazil: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 82 Brazil: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
Table 83 Argentina: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
Table 84 Argentina: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
Table 85 Argentina: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Cloning And Mutagenesis Market, 2018 - 2030 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Technology
Figure 7. Global Cloning And Mutagenesis Market, by Technology, 2021 & 2030 (USD Billion)
Figure 8. Market by Product
Figure 9. Global Cloning And Mutagenesis Market, by Product, 2021 & 2030 (USD Billion)
Figure 10. Market by End-Use
Figure 11. Global Cloning And Mutagenesis Market, by End-Use, 2021 & 2030 (USD Billion)
Figure 12. Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Figure 13. Strategic Analysis - Cloning And Mutagenesis Market

Product Code: PM2936

The global cloning and mutagenesis market size is expected to reach USD 9.29 billion by 2030, according to a new study by Polaris Market Research. The report "Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global increase in the DNA and gene cloning services market is driven by the advancement of DNA sequencing technology, its growing application in clinical diagnostics and drug discovery, and an increase in R&D spending. Forensics, reproductive health, customized medicine, biomarkers, and diagnostics are just a few fields in which DNA sequencing is used. Recent research has shown that next-generation sequencing (NGS) technology can quickly and economically find and characterize clinically relevant genetic variations across various genes in a single test. Companies are also providing sequencing services. For instance, in December 2020, Eurofins Genomics introduced cost-effective and optimized SARS-CoV-2 NGS services, enabling the sequencing of the whole viral genome.

The purpose of gene therapy is to treat diseases by modifying genetic material, such as deactivating faulty genes or exchanging a disease-causing gene for a healthy copy. Various illnesses are being treated with gene therapy efficiently. Gene therapy can treat conditions like AIDS, diabetes, cancer, and heart disease.

The market is driven by a strong product portfolio, increased investment by major players, a high prevalence of target diseases, and interest in novel & innovative therapies. However, high product development costs and strict management standards are projected to constrain the global market. Increased R&D spending by public and private institutions is anticipated to open up new prospects in the worldwide cloning and mutagenesis market.

The COVID-19 epidemic has benefited the global market because lockdown measures have been implemented in many nations, which has increased the use of PCR for the detection and analysis of particular gene sequences, which primarily utilizes oligonucleotides as a primer, functioning as a catalyst for industry expansion. Oligonucleotides are widely employed in the biopharmaceutical sector for dsDNA binding, aptamer creation, and allele-specific tests. Moreover, the market is anticipated to present attractive potential in the upcoming years due to the growing utilization of DNA computing, CRISPR gene editing, and mutagenesis investigations.

Cloning And Mutagenesis Market Report Highlights

In 2021, the TOPO PCR category dominated the market. TOPO PCR cloning is seeing increased use across a variety of end users, including pharmaceutical and biotech corporations and academic and research institutions.

The pharmaceutical and biopharmaceutical companies dominated the revenue in 2021. Pharmaceutical and biopharmaceutical companies are focusing on drug discovery and development due to the rise in disease frequency.

North America emerged as the largest regional share in 2021. This substantial percentage can be attributed to the increased demand for biotechnology techniques. Cloning and mutagenesis methods have also become more popular in the region as platforms based on genomic and proteomic data have grown.

The global players include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd.

Polaris Market Research has segmented the cloning and mutagenesis market report based on product, technology, end-use, and region:

Cloning And Mutagenesis, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Cloning Kits

Mutagenesis Kits

Cloning And Mutagenesis, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

TOPO PCR Cloning

Site-directed Mutagenesis

Cloning And Mutagenesis, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Biopharmaceuticals and pharmaceutical companies

CROs and CMOS

Cloning And Mutagenesis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cloning And Mutagenesis Market Insights

4.1. Cloning And Mutagenesis - Industry Snapshot
4.2. Cloning And Mutagenesis Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising demand for genetically modified products
  - 4.2.1.2. Increasing demand for personalized medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High maintenance cost associated with cloning and mutagenesis tools & instruments
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cloning And Mutagenesis Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cloning And Mutagenesis Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
5.3. Cloning Kits
- 5.3.1. Global Cloning And Mutagenesis Market, by Cloning Kits, by Region, 2018 - 2030 (USD Billion)
5.4. Mutagenesis Kits
- 5.4.1. Global Cloning And Mutagenesis Market, by Mutagenesis Kits, by Region, 2018 - 2030 (USD Billion)

6. Global Cloning And Mutagenesis Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
6.3. TOPO PCR Cloning
- 6.3.1. Global Cloning And Mutagenesis Market, by TOPO PCR Cloning, by Region, 2018 - 2030 (USD Billion)
6.4. Site-directed Mutagenesis
- 6.4.1. Global Cloning And Mutagenesis Market, by Site-directed Mutagenesis, by Region, 2018 - 2030 (USD Billion)

7. Global Cloning And Mutagenesis Market, by End-Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
7.3. Biopharmaceuticals and pharmaceutical companies
- 7.3.1. Global Cloning And Mutagenesis Market, by Biopharmaceuticals and pharmaceutical companies, by Region, 2018 - 2030 (USD Billion)
7.4. CROs and CMOs
- 7.4.1. Global Cloning And Mutagenesis Market, by CROs and CMOs, by Region, 2018 - 2030 (USD Billion)

8. Global Cloning And Mutagenesis Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
8.3. Cloning And Mutagenesis Market - North America
- 8.3.1. North America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.3.2. North America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.3.3. North America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.3.4. Cloning And Mutagenesis Market - U.S.
  - 8.3.4.1. U.S.: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.3.4.2. U.S.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.3.4.3. U.S.: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.3.5. Cloning And Mutagenesis Market - Canada
  - 8.3.5.1. Canada: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.3.5.2. Canada.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.3.5.3. Canada: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4. Cloning And Mutagenesis Market - Europe
- 8.4.1. Europe: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.4.2. Europe.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.4.3. Europe: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.4. Cloning And Mutagenesis Market - UK
  - 8.4.4.1. UK: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.4.2. UK.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.4.3. UK: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.5. Cloning And Mutagenesis Market - France
  - 8.4.5.1. France: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.5.2. France.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.5.3. France: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.6. Cloning And Mutagenesis Market - Germany
  - 8.4.6.1. Germany: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.6.2. Germany.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.6.3. Germany: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.7. Cloning And Mutagenesis Market - Italy
  - 8.4.7.1. Italy: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.7.2. Italy.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.7.3. Italy: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.8. Cloning And Mutagenesis Market - Spain
  - 8.4.8.1. Spain: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.8.2. Spain.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.8.3. Spain: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.9. Cloning And Mutagenesis Market - Netherlands
  - 8.4.9.1. Netherlands: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.9.2. Netherlands.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.9.3. Netherlands: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.4.10. Cloning And Mutagenesis Market - Russia
  - 8.4.10.1. Russia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.4.10.2. Russia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.4.10.3. Russia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5. Cloning And Mutagenesis Market - Asia Pacific
- 8.5.1. Asia Pacific: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.5.2. Asia Pacific.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.5.3. Asia Pacific: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.4. Cloning And Mutagenesis Market - China
  - 8.5.4.1. China: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.4.2. China.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.4.3. China: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.5. Cloning And Mutagenesis Market - India
  - 8.5.5.1. India: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.5.2. India.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.5.3. India: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.6. Cloning And Mutagenesis Market - Malaysia
  - 8.5.6.1. Malaysia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.6.2. Malaysia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.6.3. Malaysia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.7. Cloning And Mutagenesis Market - Japan
  - 8.5.7.1. Japan: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.7.2. Japan.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.7.3. Japan: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.8. Cloning And Mutagenesis Market - Indonesia
  - 8.5.8.1. Indonesia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.8.2. Indonesia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.8.3. Indonesia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.5.9. Cloning And Mutagenesis Market - South Korea
  - 8.5.9.1. South Korea: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.5.9.2. South Korea.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.5.9.3. South Korea: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6. Cloning And Mutagenesis Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.6.2. Middle East & Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.6.3. Middle East & Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.4. Cloning And Mutagenesis Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.5. Cloning And Mutagenesis Market - UAE
  - 8.6.5.1. UAE: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.5.2. UAE.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.5.3. UAE: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.6. Cloning And Mutagenesis Market - Israel
  - 8.6.6.1. Israel: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.6.2. Israel.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.6.3. Israel: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.6.7. Cloning And Mutagenesis Market - South Africa
  - 8.6.7.1. South Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.6.7.2. South Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.6.7.3. South Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7. Cloning And Mutagenesis Market - Latin America
- 8.7.1. Latin America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
- 8.7.2. Latin America.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
- 8.7.3. Latin America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.4. Cloning And Mutagenesis Market - Mexico
  - 8.7.4.1. Mexico: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.4.2. Mexico.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.4.3. Mexico: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.5. Cloning And Mutagenesis Market - Brazil
  - 8.7.5.1. Brazil: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.5.2. Brazil.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.5.3. Brazil: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
- 8.7.6. Cloning And Mutagenesis Market - Argentina
  - 8.7.6.1. Argentina: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
  - 8.7.6.2. Argentina.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
  - 8.7.6.3. Argentina: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Agilent Technologies, Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Thermo Fisher Scientific, Inc
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. New England Biolabs
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Takara Bio Inc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Merck KGaA
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Bio-Rad Laboratories, Inc
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Danaher
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Jena Bioscience GmbH
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Assay Genie
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. TransGen Biotech Co., Ltd
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

クローニング・突然変異誘発の世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、製品別、技術別、最終用途別、地域別、セグメント予測

Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のクローニング・突然変異誘発市場：洞察

第5章世界のクローニング・突然変異誘発市場：製品別

第6章世界のクローニング・突然変異誘発市場：技術別

第7章世界のクローニング・突然変異誘発市場：最終用途別

第8章世界のクローニング・突然変異誘発市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables

List of Figures

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Cloning And Mutagenesis Market Insights

5. Global Cloning And Mutagenesis Market, by Product

6. Global Cloning And Mutagenesis Market, by Technology

7. Global Cloning And Mutagenesis Market, by End-Use

8. Global Cloning And Mutagenesis Market, by Geography

9. Competitive Landscape

10. Company Profiles

クローニング・突然変異誘発の世界市場（2022年～2030年）：市場シェア、規模、動向、業界分析、製品別、技術別、最終用途別、地域別、セグメント予測

Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のクローニング・突然変異誘発市場：洞察

第5章 世界のクローニング・突然変異誘発市場：製品別

第6章 世界のクローニング・突然変異誘発市場：技術別

第7章 世界のクローニング・突然変異誘発市場：最終用途別

第8章 世界のクローニング・突然変異誘発市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables

List of Figures

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Cloning And Mutagenesis Market Insights

5. Global Cloning And Mutagenesis Market, by Product

6. Global Cloning And Mutagenesis Market, by Technology

7. Global Cloning And Mutagenesis Market, by End-Use

8. Global Cloning And Mutagenesis Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界のクローニング・突然変異誘発市場：洞察

第5章世界のクローニング・突然変異誘発市場：製品別

第6章世界のクローニング・突然変異誘発市場：技術別

第7章世界のクローニング・突然変異誘発市場：最終用途別

第8章世界のクローニング・突然変異誘発市場：地域別

第9章競合情勢

第10章企業プロファイル